» Articles » PMID: 39544895

Efficacy and Safety of Digital Nerve Block for Pain Management During Sharp Debridement of Digital Ulcers in Systemic Sclerosis: A Prospective Observational Study

Overview
Date 2024 Nov 15
PMID 39544895
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and vascular abnormalities, often leading to the development of digital ulcers (DUs). DUs are painful and debilitating, significantly impacting patients' quality of life. Effective pain management during debridement is crucial, yet there is no consensus on the optimal approach. This study evaluates the efficacy and safety of digital nerve block (DNB) using lidocaine and mepivacaine for pain control during sharp debridement of DUs in SSc patients.

Methods: This prospective observational study was conducted from September 2023 to May 2024 at the Rheumatology Operating Unit, University of Verona. Patients were randomized to receive either 1 mL of 2% lidocaine or 2% mepivacaine for DNB. Pain levels were assessed using a categorical grading scale during the injection and debridement. The outcomes were pain control and performance of lidocaine versus mepivacaine.

Results: The cohort developed 46 ulcers. The pain was abolished in almost all patients. Lidocaine achieved faster anaesthesia (127.92 ± 34.32 s) compared with mepivacaine (252.65 ± 49.89 s,  < 0.001). Mepivacaine resulted in less pain during injection ( = 0.006). No significant difference in pain levels during debridement was observed between the two anaesthetics. Three mild adverse effects (Raynaud's phenomenon) were reported. All procedures were completed successfully, and 35 ulcers healed with a mean time of 6.1 ± 7.77 weeks.

Conclusions: DNB with mepivacaine provides effective pain control during DU debridement in SSc patients, with lower injection site pain and comparable efficacy to lidocaine. The procedure is safe, well-tolerated and facilitates successful ulcer healing. Further studies with larger cohorts are warranted to confirm these findings.

References
1.
Ayello E, Dowsett C, Schultz G, Sibbald R, Falanga V, Harding K . TIME heals all wounds. Nursing. 2004; 34(4):36-41. DOI: 10.1097/00152193-200404000-00040. View

2.
Mouthon L, Mestre-Stanislas C, Berezne A, Rannou F, Guilpain P, Revel M . Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis. 2009; 69(1):214-7. DOI: 10.1136/ard.2008.094193. View

3.
Su N, Liu Y, Yang X, Shi Z, Huang Y . Efficacy and safety of mepivacaine compared with lidocaine in local anaesthesia in dentistry: a meta-analysis of randomised controlled trials. Int Dent J. 2014; 64(2):96-107. PMC: 9376404. DOI: 10.1111/idj.12087. View

4.
Hughes M, Alcacer-Pitarch B, Allanore Y, Baron M, Boin F, Bruni C . Digital ulcers: should debridement be a standard of care in systemic sclerosis?. Lancet Rheumatol. 2024; 2(5):e302-e307. DOI: 10.1016/S2665-9913(19)30164-X. View

5.
Schultz G, Sibbald R, Falanga V, Ayello E, Dowsett C, Harding K . Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11 Suppl 1:S1-28. DOI: 10.1046/j.1524-475x.11.s2.1.x. View